These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7678410

  • 21. Generation of a monoclonal antibody to P-glycoprotein peptides using tuberculin-PPD as a carrier.
    Bashir I, Sikora K, Foster CS.
    Virchows Arch; 1998 Mar; 432(3):279-87. PubMed ID: 9532008
    [Abstract] [Full Text] [Related]

  • 22. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.
    Kulkarni SS, Wang ZM, Spitzer G, Taha M, Hamada H, Tsuruo T, Dicke KA.
    Blood; 1989 Nov 01; 74(6):2244-51. PubMed ID: 2572283
    [Abstract] [Full Text] [Related]

  • 23. Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein.
    Matsuo H, Wakasugi M, Takanaga H, Ohtani H, Naito M, Tsuruo T, Sawada Y.
    J Control Release; 2001 Nov 09; 77(1-2):77-86. PubMed ID: 11689261
    [Abstract] [Full Text] [Related]

  • 24. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters.
    Currier SJ, Kane SE, Willingham MC, Cardarelli CO, Pastan I, Gottesman MM.
    J Biol Chem; 1992 Dec 15; 267(35):25153-9. PubMed ID: 1360983
    [Abstract] [Full Text] [Related]

  • 25. Characterization and epitope mapping of several new anti-P-glycoprotein monoclonal antibodies.
    Shapiro AB, Duthie M, Childs S, Okubo T, Ling V.
    Int J Cancer; 1996 Jul 17; 67(2):256-63. PubMed ID: 8760596
    [Abstract] [Full Text] [Related]

  • 26. Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies.
    Watanabe T, Naito M, Kokubu N, Tsuruo T.
    J Natl Cancer Inst; 1997 Apr 02; 89(7):512-8. PubMed ID: 9086008
    [Abstract] [Full Text] [Related]

  • 27. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1).
    Liu B, Sun D, Xia W, Hung MC, Yu D.
    J Natl Cancer Inst; 1997 Oct 15; 89(20):1524-9. PubMed ID: 9337349
    [Abstract] [Full Text] [Related]

  • 28. The extracellular loop between TM5 and TM6 of P-glycoprotein is required for reactivity with monoclonal antibody UIC2.
    Zhou Y, Gottesman MM, Pastan I.
    Arch Biochem Biophys; 1999 Jul 01; 367(1):74-80. PubMed ID: 10375401
    [Abstract] [Full Text] [Related]

  • 29. Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12.
    Greenberger LM.
    J Biol Chem; 1993 May 25; 268(15):11417-25. PubMed ID: 8098711
    [Abstract] [Full Text] [Related]

  • 30. In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody.
    Dinota A, Tazzari PL, Michieli M, Visani G, Gobbi M, Bontadini A, Tassi C, Fanin R, Damiani D, Grandi M.
    Cancer Res; 1990 Jul 15; 50(14):4291-4. PubMed ID: 1694719
    [Abstract] [Full Text] [Related]

  • 31. Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence.
    Kast C, Canfield V, Levenson R, Gros P.
    J Biol Chem; 1996 Apr 19; 271(16):9240-8. PubMed ID: 8621583
    [Abstract] [Full Text] [Related]

  • 32. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines.
    Chu TM, Kawinski E, Lin TH.
    Hybridoma; 1993 Aug 19; 12(4):417-29. PubMed ID: 7503940
    [Abstract] [Full Text] [Related]

  • 33. Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3.
    Kast C, Canfield V, Levenson R, Gros P.
    Biochemistry; 1995 Apr 04; 34(13):4402-11. PubMed ID: 7535563
    [Abstract] [Full Text] [Related]

  • 34. Functionally active homodimer of P-glycoprotein in multidrug-resistant tumor cells.
    Naito M, Tsuruo T.
    Biochem Biophys Res Commun; 1992 May 29; 185(1):284-90. PubMed ID: 1350903
    [Abstract] [Full Text] [Related]

  • 35. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
    Babas T, Le Grand R, Dormont D, Bahraoui E.
    AIDS Res Hum Retroviruses; 1997 Sep 01; 13(13):1109-19. PubMed ID: 9282816
    [Abstract] [Full Text] [Related]

  • 36. High-level expression of MRK 16 and MRK 20 murine monoclonal antibody-define proteins (170,000-180,000 P-glycoprotein and 85,000 protein) in leukaemias and malignant lymphomas.
    Sugawara I, Kodo H, Ohkochi E, Hamada H, Tsuruo T, Mori S.
    Br J Cancer; 1989 Oct 01; 60(4):538-41. PubMed ID: 2572270
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies.
    Yoshimura A, Kuwazuru Y, Sumizawa T, Ichikawa M, Ikeda S, Uda T, Akiyama S.
    J Biol Chem; 1989 Sep 25; 264(27):16282-91. PubMed ID: 2476441
    [Abstract] [Full Text] [Related]

  • 39. Isolation of antigenic mimics of MDR1-P-glycoprotein by phage-displayed peptide libraries.
    Poloni F, Romagnoli G, Cianfriglia M, Felici F.
    Int J Cancer; 1995 May 29; 61(5):727-31. PubMed ID: 7768648
    [Abstract] [Full Text] [Related]

  • 40. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
    Sela S, Husain SR, Pearson JW, Longo DL, Rahman A.
    J Natl Cancer Inst; 1995 Jan 18; 87(2):123-8. PubMed ID: 7707383
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.